Singh P, Agnese D, Amin M, Barrio A, van den Bruele A, Burke E
Ann Surg Oncol. 2024; 31(4):2212-2223.
PMID: 38261126
DOI: 10.1245/s10434-024-14893-x.
Makhnoon S, Gutierrez Barrera A, Bassett R, Afrough A, Bedrosian I, Arun B
Breast J. 2023; 2022:1447545.
PMID: 36685664
PMC: 9825211.
DOI: 10.1155/2022/1447545.
Ain Q, Richardson C, Mutebi M, George A, Kemp Z, Rusby J
Breast. 2022; 67:30-35.
PMID: 36577271
PMC: 9982265.
DOI: 10.1016/j.breast.2022.12.001.
Hersh E, King T
Breast. 2021; 62 Suppl 1:S43-S49.
PMID: 34949533
PMC: 9097808.
DOI: 10.1016/j.breast.2021.11.018.
Armstrong J, Lynch K, Virgo K, Schwartz M, Friedman S, Dean M
JCO Oncol Pract. 2021; 17(2):e226-e235.
PMID: 33567243
PMC: 8202055.
DOI: 10.1200/OP.20.00571.
Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer.
Valero M, Moo T, Muhsen S, Zabor E, Stempel M, Pusic A
Br J Surg. 2020; 107(10):1307-1312.
PMID: 32432359
PMC: 7938823.
DOI: 10.1002/bjs.11616.
Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer Who Are Genetic Carriers, Have a Strong Family History or Are just Young at Presentation.
Teoh V, Tasoulis M, Gui G
Cancers (Basel). 2020; 12(1).
PMID: 31935898
PMC: 7016894.
DOI: 10.3390/cancers12010140.
Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: Data from California, 1998 through 2015.
Kurian A, Canchola A, Ma C, Clarke C, Gomez S
Cancer. 2019; 126(5):958-970.
PMID: 31750934
PMC: 7021576.
DOI: 10.1002/cncr.32618.
Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
Christian N, Zabor E, Cassidy M, Flynn J, Morrow M, Gemignani M
Ann Surg Oncol. 2019; 27(3):743-749.
PMID: 31732944
PMC: 7004848.
DOI: 10.1245/s10434-019-08038-8.
Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.
Squires J, Simard S, Asad S, Stacey D, Graham I, Coughlin M
Curr Oncol. 2019; 26(4):e439-e457.
PMID: 31548812
PMC: 6726273.
DOI: 10.3747/co.26.4951.
Patient decision aid for contralateral prophylactic mastectomy for use in the consultation: a feasibility study.
Squires J, Stacey D, Coughlin M, Greenough M, Roberts A, Dorrance K
Curr Oncol. 2019; 26(2):137-148.
PMID: 31043816
PMC: 6476460.
DOI: 10.3747/co.26.4689.
Genetic ablation of mammary ducts through foxa1 prevents breast cancer occurrence.
Zheng D, McLaughlin S, Kaestner K, Li Z
Am J Cancer Res. 2019; 9(2):424-428.
PMID: 30906639
PMC: 6405962.
Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact.
Bouchard-Fortier A, Baxter N, Sutradhar R, Fernandes K, Camacho X, Graham P
Curr Oncol. 2019; 25(6):e562-e568.
PMID: 30607124
PMC: 6291287.
DOI: 10.3747/co.25.4169.
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature.
Alaofi R, Nassif M, Al-Hajeili M
Avicenna J Med. 2018; 8(3):67-77.
PMID: 30090744
PMC: 6057165.
DOI: 10.4103/ajm.AJM_21_18.
Risk-reducing mastectomy for the prevention of primary breast cancer.
Carbine N, Lostumbo L, Wallace J, Ko H
Cochrane Database Syst Rev. 2018; 4:CD002748.
PMID: 29620792
PMC: 6494635.
DOI: 10.1002/14651858.CD002748.pub4.
Sentinel Lymph Node Biopsy in Breast Cancer: A Clinical Review and Update.
Zahoor S, Haji A, Battoo A, Qurieshi M, Mir W, Shah M
J Breast Cancer. 2017; 20(3):217-227.
PMID: 28970846
PMC: 5620435.
DOI: 10.4048/jbc.2017.20.3.217.
Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies K, Brewster A, Bedrosian I, Parker P, Crosby M, Peterson S
Breast Cancer Res. 2016; 18(1):93.
PMID: 27650678
PMC: 5028980.
DOI: 10.1186/s13058-016-0752-y.
Contralateral prophylactic mastectomy and its impact on quality of life.
Hieken T, Boughey J
Gland Surg. 2016; 5(4):439-43.
PMID: 27562384
PMC: 4971345.
DOI: 10.21037/gs.2016.05.05.
Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
Boughey J, Attai D, Chen S, Cody H, Dietz J, Feldman S
Ann Surg Oncol. 2016; 23(10):3100-5.
PMID: 27469117
PMC: 4999465.
DOI: 10.1245/s10434-016-5443-5.
Contralateral prophylactic mastectomy: current perspectives.
Yao K, Sisco M, Bedrosian I
Int J Womens Health. 2016; 8:213-23.
PMID: 27382334
PMC: 4922807.
DOI: 10.2147/IJWH.S82816.